Outlook Therapeutics Inc
F:41ON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Outlook Therapeutics Inc
F:41ON
|
US |
|
P
|
PT Solusi Kemasan Digital Tbk
IDX:PACK
|
ID |
|
Beowulf Mining PLC
LSE:BEM
|
UK |
|
Erste Group Bank AG
OTC:EBKDY
|
AT |
|
Johnson Matthey PLC
LSE:JMAT
|
UK |
|
Granite Ridge Resources Inc
F:Y60
|
US |
|
M
|
Minor International PCL
SET:MINT
|
TH |
|
Concentrix Corp
F:CO8
|
US |
|
C
|
Credit Saison Co Ltd
DUS:QC9
|
JP |
|
B
|
Befesa SA
SWB:BFSA
|
LU |
|
G
|
Grenke AG
DUS:GLJ
|
DE |
|
Adolfo Dominguez SA
MAD:ADZ
|
ES |
|
V
|
Virtus Investment Partners Inc
F:VIP
|
US |
|
Centrica PLC
F:CENN
|
UK |
|
Lords Group Trading PLC
LSE:LORD
|
UK |
|
Skyline Champion Corp
NYSE:SKY
|
US |
|
B
|
Bear Creek Mining Corp
F:OU6
|
CA |
|
Coor Service Management Holding AB
F:COE
|
SE |
|
Urban Edge Properties
NYSE:UE
|
US |
|
Telecom Egypt Co SAE
LSE:TEEG
|
EG |
|
Fraport Frankfurt Airport Services Worldwide AG
F:FRAS
|
DE |
|
M
|
Mitchells & Butlers PLC
DUS:MABB
|
UK |
Wall St Price Targets
41ON Price Targets Summary
Outlook Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 41ON is 8.936 EUR with a low forecast of 0.804 EUR and a high forecast of 16.726 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41ON's stock price target?
Price Target
8.936
EUR
According to Wall Street analysts, the average 1-year price target for 41ON is 8.936 EUR with a low forecast of 0.804 EUR and a high forecast of 16.726 EUR.
What is the Revenue forecast for Outlook Therapeutics Inc?
Projected CAGR
55%
Over the last 10 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 55%.
What is the Gross Profit forecast for Outlook Therapeutics Inc?
Projected CAGR
558%
The compound annual growth rate for Gross Profit over the next 3 years is 558%.
